comparemela.com

Latest Breaking News On - Berok zindagi - Page 3 : comparemela.com

Relatability has been an important aspect of Cipla's inhaler campaign: Dr Vikas Gupta

Relatability has been an important aspect of Cipla's inhaler campaign: Dr Vikas Gupta
adgully.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from adgully.com Daily Mail and Mail on Sunday newspapers.

India
Vikas-gupta
Berok-zindagi
Priyanshu-painyuli
Sonali-bendre
Mandira-bedi
Satish-kaushik
Cipla
Inhalers-hain-sahi
Breaking-inhaler-myth

Ayushmann Khurrana speaks out about Asthma

Ayushmann Khurrana speaks out about Asthma ​ By IANSlife Features ( IANS) | Published on ​ Sat, Feb 6 2021 11:27 IST | ​ 0 Views Ayushmann Khurrana speaks out about Asthma.(photo:IANSLIFE).. Image Source: IANS News New Delhi, Feb 6 : The third chapter of the #BerokZindagi campaign Asthma ke liye inhalers hain sahi (Use inhalers for Asthma) was launched with Ayushmann Khurana as the face of the campaign. The campaign focuses on the social stigma around asthma, and tries to educate patients about inhalers and their benefits in asthma management. It speaks of how inhalers help asthmatics live an unstoppable life, especially given the current situation across the world. India has an alarming of 37.9 million cases of asthma! IANSlife caught up with Khurana to speak about the social stigma associated with asthma and inhalers.

India
New-delhi
Delhi
Berok-zindagi
Ayushmann-khurana
Cipla
இந்தியா
புதியது-டெல்ஹி
டெல்ஹி
ஆயுஷ்மான்-கூரான
சிப்லா

#BerokZindagi is back with its third chapter

#BerokZindagi is back with its third chapter
adgully.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from adgully.com Daily Mail and Mail on Sunday newspapers.

India
Abhimanyu-balasubramanyam
Nilay-singh
Ayushmann-khurana
Sahil-shah
Hain-sahi
Parupalli-kashyap
Vikas-khanna
Berok-zindagi
Vikas-gupta
Ayushmann-khurrana
Instagram
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.